myocardial revascularization surgery

OCT useful to assess non ostial left main lesions

Original title:&nbsp;Frecuency domain optical coherente tomography to assess non-ostial left main artery.&nbsp;Reference:&nbsp;Francesco Burzotta, et al. EuroIntervention 2015;10e1-e8 &nbsp; Optical coherence tomography (OCT) has proved valuable in making decisions and monitoring stents implanted in coronary arteries, but its role in the assessment of left main (LM) lesions remains unclear. The study included 54 patients presenting moderate<a href="https://solaci.org/en/2015/02/09/oct-useful-to-assess-non-ostial-left-main-lesions/" title="Read more" >...</a>

The SYNTAX Score II: a tool that should be used

Original title:&nbsp;Validation and Comparison of the Long-Term Prognostic Capability of SYNTAX Store-II Among 1528 Consecutive Patients Who Underwent Left Main Percutaneous Coronary Intervention.&nbsp;Reference:&nbsp;Bo Xu, et al. JACC Cardiovascular Intervention 2014;7:1128-37. &nbsp; The SYNTAX angiography score is useful when deciding revascularization in multivessel, but with the addition of clinical variables in the second version, SYNTAX score<a href="https://solaci.org/en/2014/12/03/the-syntax-score-ii-a-tool-that-should-be-used/" title="Read more" >...</a>

Percutaneous Coronary Intervention to Unprotected Left Main Stem In Different Coronary Syndromes

Original title:&nbsp;Comparative Outcomes After Unprotected Left Main Stem Percutaneous Coronary Intervention: A National Linked Cohort Study of 5,065 Acute and Elective Cases From the BCIS Registry (British Cardiovascular Intervention Society).&nbsp;Reference:&nbsp;Sami S. Almudarra, et al. JACC Cardiovasc Interv 2014;7:717-30 Although myocardial revascularization surgery has long been the gold standard treatment for left main lesions, PCI has<a href="https://solaci.org/en/2014/08/13/percutaneous-coronary-intervention-to-unprotected-left-main-stem-in-different-coronary-syndromes/" title="Read more" >...</a>

SYNTAX study final monitoring at 5-years

Original title:&nbsp;Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.&nbsp;Reference:&nbsp;Eur Heart J. 2014 May 21. pii: ehu213. (Epub ahead of print). The SYNTAX study was one of the largest randomized clinical studies comparing long-term results of angioplasty versus surgery in multivessel disease and /or<a href="https://solaci.org/en/2014/07/04/syntax-study-final-monitoring-at-5-years/" title="Read more" >...</a>

Cohort with left main coronary injury of SYNTAX. Final monitoring at 5 years.

Original title:&nbsp;Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.&nbsp;Reference: Morice MC et al. Circulation. 2014 Jun 10;129(23):2388-94. &nbsp; Current guidelines recommend CABG as the strategy of choice for treating lesions of<a href="https://solaci.org/en/2014/06/19/cohort-with-left-main-coronary-injury-of-syntax-final-monitoring-at-5-years/" title="Read more" >...</a>

Blush reduction in a not responsible vessel is a prognostic marker in those receiving angioplasty in the culprit vessel.

Original title:&nbsp;Impact of Nonculprit Vessel Myocardial Perfusion on Outcomes of Patients Undergoing Percutaneos Coronary OIntervention for Acute Coronary S&iacute;ndromes. Analysis From ACUITY Trial.&nbsp;Reference:&nbsp;Alexandra Lansky, et al. JAAC Cardiovascular Intervention 2014,7:266-275 In Non ST elevation Acute Coronary Syndrome (NSTE-ACS) is demonstrated that revascularization of the culprit vessel is beneficial, but strategy it is not yet clear<a href="https://solaci.org/en/2014/05/09/blush-reduction-in-a-not-responsible-vessel-is-a-prognostic-marker-in-those-receiving-angioplasty-in-the-culprit-vessel/" title="Read more" >...</a>

The FFR changes the treatment strategy in almost half of patients

Original title:&nbsp;Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography.&nbsp;Reference:&nbsp;Van Belle E et al. Circulation. 2014 Jan 14;129(2):173-85. Any comprehensive registry has not been yet published that evaluates the impact of fractional coronary flow reserve (FFR) to change the strategy of revascularization on individual patients referred for diagnostic<a href="https://solaci.org/en/2014/01/29/the-ffr-changes-the-treatment-strategy-in-almost-half-of-patients/" title="Read more" >...</a>

Ischemic versus anatomical risk. Is anyone better to help us decide therapeutically?

Original title:&nbsp;Predicting Outcome in the COURAGE Trial. Coronary Anatomy Versus Ischemia.&nbsp;Reference:&nbsp;G. B. John Mancini et al. J Am Coll Cardiol Intv 2013,&nbsp;Article in press. &nbsp; Anatomical risk, ischemic amount or a combination of both, are often factors taken into account for estimating the prognosis or choose a treatment strategy. The COURAGE study (Clinical Outcomes Utilizing<a href="https://solaci.org/en/2014/01/24/ischemic-versus-anatomical-risk-is-anyone-better-to-help-us-decide-therapeutically/" title="Read more" >...</a>

The largest series of post TAVI coronary occlusion published

Original title:&nbsp;Predictive Factors, Management and Clinical Outcomes of Coronary obstruction Following Transcatheter Aortic Valve Implantation Insight From a Large Multicenter Registry&nbsp;Reference:&nbsp;Henrique B. Ribeiro, et; al. J Am Coll Cardiology 2013;62:1552-62 Percutaneous implantation of the aortic valve is a valid strategy in high-risk surgical patients. One of the possible complications of this procedure is the occlusion<a href="https://solaci.org/en/2013/10/29/the-largest-series-of-post-tavi-coronary-occlusion-published/" title="Read more" >...</a>

Ticagrelor effective in venous bridges

Original title:&nbsp;Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass grafo surgery: Inssights from th PLATelet inhibition and patients outcomes (PLATO) trial.&nbsp;Reference:&nbsp;Emmanouil S. Brilakis, et al. Am Heart J 2013;166:474-80 &nbsp; The bridge venous occlusion is a common finding in patients with previous CABG presenting with acute coronary syndrome without ST<a href="https://solaci.org/en/2013/09/27/ticagrelor-effective-in-venous-bridges/" title="Read more" >...</a>

Top